Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 07:35 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Anakinra, COVID-19, Cytokine Storm
NCT04603742 · Weill Medical College of Cornell University · PHASE2 · withdrawn · last registry update 2022-01-25 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Funding did not go through” | – | Registry record, Weill Medical College of Cornell University |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against IL1R1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-08-12Phase 3 first posted: Herlev and Gentofte Hospital, Anakinra + Sodium Chloride 9mg/ml Injection (NCT05498467)
- 2022-06-08Also stopped (withdrawn): University of North Carolina, Chapel Hill, Anakinra + Preservative-free 0.9% sodium chloride (Placebo) (NCT04035109)
- 2022-04-05Also stopped (terminated): Fundacion Clinic per a la Recerca Biomédica, Plasma exchange + Standar medical treatmen (NCT04374539)
- 2022-03-10Results posted on the registry: Swedish Orphan Biovitrum, Emapalumab + Anakinra (NCT04324021)
- 2022-03-10Also stopped (terminated): Swedish Orphan Biovitrum, Emapalumab + Anakinra (NCT04324021)
- 2022-03-04Phase 3 first posted: Nationwide Children's Hospital, Anakinra + Placebo (NCT05267821)
- 2021-11-24Also stopped (terminated): Cale Jacobs, PhD, anakinra (150mg) (NCT02930122)
- 2021-10-27Results posted on the registry: Cale Jacobs, PhD, anakinra (150mg) (NCT02930122)
- 2021-06-30Also stopped (terminated): Swedish Orphan Biovitrum, anakinra + Placebo (NCT03265132)
- 2021-06-11Also stopped (withdrawn): Oslo University Hospital, Anakinra 100 mg in 2 ml saline IA (NCT01997138)
- 2021-05-24Phase 3 first posted: University of California, San Diego, Infliximab + Anakinra (NCT04898231)
- 2021-05-14Also stopped (withdrawn): University of North Carolina, Chapel Hill, Anakinra + Dermatophagoides Farinae (NCT03513458)
- 2021-05-07Also stopped (withdrawn): University of North Carolina, Chapel Hill, Anakinra + Dermatophagoides Farinae (NCT03513471)
- 2021-04-30Results posted on the registry: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Anakinra (NCT01794117)
- 2021-04-30Also stopped (terminated): University of Manchester, Anakinra 100Mg/0.67Ml Inj Syringe (NCT04462757)
- 2021-04-01Phase 3 first posted: University Children's Hospital Basel, Methylprednisolone sodium succinate 10 mg/kg intravenously + Human normal immunoglobulin (IVIg) (NCT04826588)
- 2021-02-23Results posted on the registry: Virginia Commonwealth University, Anakinra + Placebo (NCT03224585)
- 2021-02-23Also stopped (terminated): Virginia Commonwealth University, Anakinra + Placebo (NCT03224585)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision